Premium
Prognostically favorable immunogens of human breast cancer tissue: Antigenic similarity to murine mammary tumor virus
Author(s) -
Black Maurice M.,
Zachrau Reinhard E.,
Shore Bella,
Moore Dan H.,
Leis Henry P.
Publication year - 1975
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(197501)35:1<121::aid-cncr2820350117>3.0.co;2-w
Subject(s) - antigenicity , immunogenicity , mouse mammary tumor virus , medicine , antigen , breast cancer , cancer , delayed hypersensitivity , immunology , mammary tumor , virus , syngenic , mammary gland , cancer research , immune system
A leukocyte migration procedure was utilized to test cellular hypersensitivity of breast cancer patients' leukocytes to autologous and homologous breast cancer tissues and to murine milk containing murine mammary tumor virus (MuMTV). The in vitro responsiveness of the leukocytes and the antigenicity of breast cancer tissues were compared with in vivo prognostically favorable lymphoreticuloendothelial (L‐RE) responses seen microscopically at the time of mastectomy and with the results of skin window tests of cellular hypersensitivity. The data suggest that immunogens appear in the in situ phase of the disease and provoke prognostically favorable L‐RE responses. These immunogens possess antigenic similarity to some component(s) of MuMTV. Progression of the disease is associated with or preceded by a loss of tissue immunogenicity and/or diminished specific cellular hypersensitivity. The findings are pertinent to investigations of human mammary carcinogenesis and immunoprophylaxis.